Why Integrated Drug Discovery Must Focus On Drug Repurposing

Drug repurposing is an effective strategy for identifying new uses for existing approved or shelved therapeutics. Integrated drug discovery services must include drug repurposing in their strategy. This will allow them to determine new starting points for projects without too many hassles. History suggests that repurposing happens mostly by accident rather than by design. But advanced technology and new research methods enable agencies to adopt a systematic repositioning approach. Inventing a new therapeutic takes more than an average of 10 years and over a billion dollars. The drug discovery and development industry require new and inventive measures to reduce their investments and timelines. Below are a few strong reasons why a contract research organization in India and elsewhere must include repositioning in its plans. 

1. Reduced Research and Development Costs

 The best thing about repurposing is that you do not have to start everything from scratch. You already have a product or a therapeutic that did not get the approval for a particular illness or condition. Repositioning allows you to save the money that would have otherwise been spent on starting fresh research work. Your drug discovery laboratories can use the saved money to conduct research in identifying targets and lead compounds for other therapeutic areas. A CRO can also use the money in enhancing its infrastructure. 

2. Shorter Drug Development Timeline

 As mentioned before, developing a new medicine can take more than 10 years. Drug manufacturing companies are always looking for ways to reduce this timeline. Even integrated drug discovery agencies are exploring new ideas to expedite clinical and preclinical research. Repurposing an existing approved/ shelved drug allows both entities to accelerate their processes. Every business is interested in reducing its time to market and drug manufacturers are no different. Including repositioning in your approach will help you in expediting your work and achieve quick results. 

3. Take Advantage of Reduced Development Risks

 More often than not drug discovery services and manufacturing companies are saddled with libraries of approved or potentially safe buy not marketable drugs. The main reason why these therapeutics never reached the market was that they exhibited undesirable molecular promiscuity. But this same feature allows them to be explored for other uses. It also means that the therapeutics have been found to be largely safe during later-stage trials. This means that the development risks involved in working with such products are less. 

Get In Touch With Integral BioSciences for Top-Grade Integrated Drug Discovery Services

 Drug repositioning must be a part of the business strategy of not only manufacturers but also CROs. Integral BioSciences is a top-notch contract research organization in India offering efficient services to pharma and biopharma companies. It has helped clients develop numerous preclinical molecules and five clinical candidates in addition to two approved drugs. The agency has a team of experienced scientists with expertise in organic and medicinal chemistry and biology studies. It follows all the best practices and industry guidelines to ensure thoroughly professional services for its clients. Contact Integral BioSciences today to get integrated drug discovery services to expedite your drug development project.

Read More: 
7 Steps All Drug Discovery Services Follow For Efficient Results